Refined balloon pulmonary angioplasty-A therapeutic option in very elderly patients with chronic thromboembolic pulmonary hypertension.

Marek F RoikDominik WretowskiAndrzej ŁabykKatarzyna IrzykBarbara LichodziejewskaOlga Dzikowska-DiduchDorota Piotrowska-KownackaPiotr Pruszczyk

Published in: Journal of interventional cardiology (2017)

This study demonstrated the safety and efficacy of refined BPA in CTEPH patients aged 75 or over, disqualified from PEA. Refined BPA may emerge as an alternative therapeutic strategy in very elderly CTEPH patients who are suitable for surgery, but this requires further validation in a large prospective study.

Keyphrases

pulmonary hypertension
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
coronary artery disease
atrial fibrillation
coronary artery
pulmonary artery
coronary artery bypass
community dwelling
patient reported